Purification of melanoma growth stimulatory activity
Abstract
The Hs0294 human malignant melanoma cell line produces a monolayer mitogen that stimulates the serum free growth of low‐density cultures of Hs0294 cells. This report describes the purification of that mitogen, termed MGSA for melanoma growth stimulatory activity, from serum‐free conditioned medium from the Hs0294 cultures. MGSA has been purified from acetic acid extracts of lyophilized conditioned medium by gel filtration, reverse‐phase high‐pressure liquid chromatography (RP‐HPLC), and preparative electrophoresis, resulting in a >400,000‐fold purification. MGSA bioactivity resides in acid‐ and heat‐stable polypeptides of high and low molecular weight (24–28 kd and < 14–16 kd). However, the majority of the activity is reproducibly associated with the ˜16‐kd moiety eluting from RP‐HPLC at ∼35% acetonitrile. Reduction with dithiothreitol or B‐mercaptoethanol results in a loss of biological activity but does not convert the 24–28‐kd moieties to the<14–16‐kd forms of MGSA. 125 l‐MGSA that has been purified by preparative electrophoresis (16 kd) specifically binds to Hs0294 melanoma cells and retains 100% of the growth‐stimulatory activity. The 16‐kd MGSA stimulates the proliferation of Hs0294 cells at concentrations of 0.3–30 pM. The electrophoretic mobility of MGSA is also unaltered by the preparative electrophoresis procedure, further demonstrating that this procedure does not alter the biochemical integrity of the growth factor. Purified MGSA does not enable anchorage‐independent growth of normal rat kidney (NRK) cells and is therefore different from the previously described transforming growth factors. The amino acid composition of MGSA differs from that of other previously described growth factors. These data demonstrate that MGSA represents a separate class of growth factors with biological and biochemical properties different from other growth factors.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In melanoma, GROα/CXCL1, GROβ/CXCL2, GROγ/CXCL3 and IL-8/CXCL8 exert autocrine control over neoplastic cell proliferation.
“Melanoma is perhaps the best exemplar in which chemokines (for example, GROα/CXCL1, GROβ/CXCL2, GROγ/CXCL3 and IL-8/CXCL8) have been shown to exert autocrine control over neoplastic cell proliferation40.”
From Inflammation and cancer (2002) · cites this paper as [40]
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · see citing works
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961 · see citing works
Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor
Kelly, K., Cochran, B., Stiles, C. D., & Leder, P. (1983) · Cell · doi:10.1016/0092-8674(83)90092-2 · Cited by 2,296 · see citing works
Derynck, R., Jarrett, J. A., Chen, E. Y., Eaton, D. H., BELL, J. R., Assoian, R. K., Roberts, A. B., Sporn, M. B., & Goeddel, D. V. (1985) · Nature · doi:10.1038/316701a0 · Cited by 1,667 · see citing works
Assoian, R. K., Komoriya, A., Meyers, C. A., Miller, D. M., & Sporn, M. B. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32345-7 · Cited by 1,597 · see citing works
Rinderknecht, E., & HUMBEL, R. E. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40889-1 · Cited by 1,548 · see citing works
Growth factors from murine sarcoma virus-transformed cells.
Larco, J. E. D., & Todaro, G. J. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.8.4001 · Cited by 1,474 · see citing works
Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer
Cuttitta, F. F., Carney, D. N., Mulshine, J. L., Moody, T. W., FEDORKO, J., Fischler, A., & Minna, J. D. (1985) · Nature · doi:10.1038/316823a0 · Cited by 1,348 · see citing works
Type beta transforming growth factor: a bifunctional regulator of cellular growth.
Roberts, A. B., Anzano, M. A., Wakefield, L. M., Roche, N. S., Stern, D. F., & Sporn, M. B. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.119 · Cited by 1,093 · see citing works
Methods for growth of cultured cells in serum-free medium
Barnes, D. W., & SATO, G. H. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90151-7 · Cited by 1,009 · see citing works
Roberts, A. B., Anzano, M. A., Lamb, L. C., Smith, J. M., & Sporn, M. B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5339 · Cited by 919 · see citing works
Todaro, G. J., Fryling, C. M., & Larco, J. E. D. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5258 · Cited by 907 · see citing works
Human transforming growth factor-α: Precursor structure and expression in E. coli
Derynck, R., Roberts, A. B., Winkler, M. E., Chen, E. Y., & Goeddel, D. V. (1984) · Cell · doi:10.1016/0092-8674(84)90550-6 · Cited by 877 · see citing works
Growth Inhibitor from BSC-1 Cells Closely Related to Platelet Type β Transforming Growth Factor
Tucker, R. F., Shipley, G. D., Moses, H. L., & Holley, R. W. (1984) · Science · doi:10.1126/science.6093254 · Cited by 768 · see citing works
Rat Transforming Growth Factor Type 1: Structure and Relation to Epidermal Growth Factor
Marquardt, H., Hunkapiller, M. W., Hood, L., & Todaro, G. J. (1984) · Science · doi:10.1126/science.6320373 · Cited by 657 · see citing works
Purification of human platelet-derived growth factor.
Antoniades, H. N., Scher, C. D., & Stiles, C. D. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.4.1809 · Cited by 583 · see citing works
Transforming growth factor production by chemically transformed cells.
Moses, H. L., Branum, E. L., Proper, J. A., & Robinson, R. A. (1981) · PubMed · Cited by 497 · see citing works
High Levels of Intracellular Bombesin Characterize Human Small-Cell Lung Carcinoma
Moody, T. W., Pert, C. B., Gazdar, A. F., et al. (1981) · Science · doi:10.1126/science.6272398 · Cited by 490 · see citing works
Frolik, C. A., Wakefield, L. M., Smith, D. M., & Sporn, M. B. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90612-5 · Cited by 471 · see citing works
Platelet-derived growth factor: purification and partial characterization.
Heldin, C., Westermark, B., & Wasteson, Å. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.8.3722 · Cited by 434 · see citing works
Marquardt, H., Hunkapiller, M. W., Hood, L., et al. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.15.4684 · Cited by 403 · see citing works
Cellular transformation by coordinated action of three peptide growth factors from human platelets
Assoian, R. K., Grotendorst, G. R., Miller, D. M., & Sporn, M. B. (1984) · Nature · doi:10.1038/309804a0 · Cited by 376 · see citing works
Expression of insulin-like growth factor-II transcripts in Wilms' tumour
Reeve, A. E., Eccles, M. R., Wilkins, R. J., Bell, G. I., & Millow, L. J. (1985) · Nature · doi:10.1038/317258a0 · Cited by 352 · see citing works
Human platelet-derived growth factor. Purification and resolution into two active protein fractions.
Deuel, T. F., Huang, J. S., Proffitt, R. T., et al. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52482-6 · Cited by 350 · see citing works
Massagué, J., & Like, B. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89408-x · Cited by 342 · see citing works
Marquardt, H., & Todaro, G. J. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34658-1 · Cited by 223 · see citing works
Computer-based characterization of epidermal growth factor precursor
Doolittle, R. F., Feng, D. F., & Johnson, M. S. (1984) · Nature · doi:10.1038/307558a0 · Cited by 210 · see citing works
Tucker, R. F., Branum, E. L., Shipley, G. D., Ryan, R. J., & Moses, H. L. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.21.6757 · Cited by 208 · see citing works
Growth factors produced by sarcoma virus-transformed cells.
Todaro, G. J., & Larco, J. E. D. (1978) · PubMed · Cited by 192 · see citing works
Heldin, C., Westermark, B., & Wasteson, Å. (1980) · Journal of Cellular Physiology · doi:10.1002/jcp.1041050207 · Cited by 187 · see citing works
The growth of mouse melanoma cells in hormone-supplemented, serum-free medium
Mather, J. P., & SATO, G. H. (1979) · Experimental Cell Research · doi:10.1016/0014-4827(79)90549-4 · Cited by 142 · see citing works
Myers, S. L., & Castor, C. W. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230506 · Cited by 140 · see citing works
Massagué, J., Kelly, B. S., & Mottola, C. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89102-5 · Cited by 134 · see citing works
Human interleukin 1. Purification to homogeneity.
Kronheim, S. R., March, C. J., Erb, S. K., et al. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.161.3.490 · Cited by 106 · see citing works
Kaplan, P. L., & Ozanne, B. W. (1983) · Cell · doi:10.1016/0092-8674(83)90036-3 · Cited by 101 · see citing works
Characterization of autostimulatory and transforming growth factors from human melanoma cells.
Richmond, A. J., Lawson, D. H., Nixon, D. W., et al. (1985) · PubMed · Cited by 99 · see citing works
Self-citationEisinger, M., Marko, O., Ogata, S., et al. (1985) · Science · doi:10.1126/science.4023718 · Cited by 95 · see citing works
Epithelial tissue-derived growth factor-like polypeptides.
Halper, J. T., & Moses, H. L. (1983) · PubMed · Cited by 84 · see citing works
Growth Factor and Cytogenetic Abnormalities in Cultured Nevi and Malignant Melanomas
Richmond, A., Fine, R. M., Murray, D. R., et al. (1986) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12285452 · Cited by 78 · see citing works
Self-citationGraves, D. T., Owen, A. J., & Antoniades, H. N. (1983) · PubMed · Cited by 73 · see citing works
Platelet-derived growth factor agonist activity of a secreted form of the v-sis oncogene product.
Johnsson, A., Betsholtz, C., von der Helm, K., et al. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.6.1721 · Cited by 72 · see citing works
Richmond, A., Lawson, D. H., Nixon, D. W., et al. (1983) · PubMed · Cited by 72 · see citing works
Self-citationHYODO, T., MEGYESI, K., Kahn, C. R., et al. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-44-6-1175 · Cited by 68 · see citing works
Castor, C. W., Ritchie, J., Williams, C. H., et al. (1979) · Arthritis & Rheumatism · doi:10.1002/art.1780220308 · Cited by 67 · see citing works
Autocrine and paracrine growth stimulation of cells derived from human skin
Gilchrest, B. A., Karassik, R. L., Wilkins, L. M., et al. (1983) · Journal of Cellular Physiology · doi:10.1002/jcp.1041170215 · Cited by 66 · see citing works
Yang, Y. W., Romanus, J. A., Liu, T. Y., et al. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89590-4 · Cited by 63 · see citing works
A PLATELET‐DERIVED GROWTH FACTOR ANALOG PRODUCED BY A HUMAN CLONAL GLIOMA CELL LINE*
Nistér, M., Heldin, C., Wasteson, Å., et al. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb43414.x · Cited by 61 · see citing works
Ectopic peptides released by a human melanoma cell line that modulate the transformed phenotype.
Larco, J. E. D., Pigott, D. A., & Lazarus, J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.15.5015 · Cited by 47 · see citing works
Production of an insulin-like growth factor by osteosarcoma
Blatt, J., White, C., Dienes, S., et al. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)90423-6 · Cited by 46 · see citing works
van Zoelen, E. J., Twardzik, D. R., van Oostwaard, T. M., et al. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.13.4085 · Cited by 45 · see citing works
Kudlow, J. E., Khosravi, M. J., Kobrin, M. S., et al. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)71296-2 · Cited by 44 · see citing works
Sherwin, S. A., Sliski, A. H., & Todaro, G. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.3.1288 · Cited by 41 · see citing works
Niman, H. L., Houghten, R. A., & Bowen‐Pope, D. F. (1984) · Science · doi:10.1126/science.6494905 · Cited by 36 · see citing works
In vitro growth promotion in human malignant melanoma cells by fibroblast growth factor.
Richmond, A., Lawson, D. H., Nixon, D. W., et al. (1982) · PubMed · Cited by 17 · see citing works
Self-citationChua, C. C., Geiman, D. E., & Ladda, R. L. (1983) · Journal of Cellular Physiology · doi:10.1002/jcp.1041170116 · Cited by 14 · see citing works
Synthesis of [3,5-125I]triiodo-l-thyronine of high specific activity
Sato, K., & CAHNMANN, H. J. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90345-0 · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111 · see citing works
Role of chemokines in tumor growth
Raman, D., Baugher, P. J., Thu, Y. M., & Richmond, A. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.05.013 · Cited by 578 · see citing works
Self-citationVicari, A. P., & Caux, C. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00033-8 · Cited by 351 · see citing works
Chemokine-protease interactions in cancer
Van Damme, J., Struyf, S., & Opdenakker, G. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.007 · Cited by 71 · see citing works
- Authors
- Richmond, A., & Thomas, H. G.
- Affiliations
- Emory University (US)
- Corresponding author
- Richmond, Ann
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 1986-12
- Volume
- 129
- Issue
- 3
- Pages
- 375-384
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2093119949
- Cited by
- 128
- References
- 56
- Citations by year
- 2023: 1 · 2022: 6 · 2021: 5 · 2020: 1 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 1 · 2012: 4
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cellular Physiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r23ca034590-03)
- National Cancer Institute (1 R23 CA 34590)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- mitogens, serum-free conditioned medium, growth factor purification, cell proliferation, anchorage-independent growth, amino acid composition, peptide growth factors
- MeSH terms
- Amino Acids, Biological Assay, Cell Line, Chromatography, Gel, Chromatography, High Pressure Liquid, DNA, Electrophoresis, Polyacrylamide Gel, Growth Substances, Humans, Melanoma, Neoplasm Proteins, Peptides, Transforming Growth Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
